100 related articles for article (PubMed ID: 34979376)
21. The circSNX14 functions as a tumor suppressor via the miR-562/ LATS2 pathway in hepatocellular carcinoma cells.
Wu Y; Yang Y; Yi X; Song L
J Mol Histol; 2023 Dec; 54(6):593-607. PubMed ID: 37861952
[TBL] [Abstract][Full Text] [Related]
22. The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.
Liu Z; Ning F; Cai Y; Sheng H; Zheng R; Yin X; Lu Z; Su L; Chen X; Zeng C; Wang H; Liu L
Cancer Commun (Lond); 2021 Jan; 41(1):62-78. PubMed ID: 34236149
[TBL] [Abstract][Full Text] [Related]
23. The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
Jung M; Ji E; Kang H; Kim C; Ryu S; Han S; Cha S; Lee EK
Biochem Biophys Res Commun; 2023 Dec; 686():149183. PubMed ID: 37926044
[TBL] [Abstract][Full Text] [Related]
24. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
[TBL] [Abstract][Full Text] [Related]
25. Apatinib Functioned as Tumor Suppressor of Synovial Sarcoma through Regulating miR-34a-5p/HOXA13 Axis.
Feng Q; Wang D; Guo P; Zhang Z; Feng J
Comput Math Methods Med; 2022; 2022():7214904. PubMed ID: 36276991
[TBL] [Abstract][Full Text] [Related]
26. LINC00355 triggers malignant progression of hepatocellular carcinoma via the sponge effect on miR-217-5p with the involvement of the Wnt/β-catenin signaling.
Luo X; ABudureyimu M; Yang G; Yan Z; Fu X; Lu P; Zhang D; Zhang S; Ding Z
J BUON; 2021; 26(5):1964-1969. PubMed ID: 34761606
[TBL] [Abstract][Full Text] [Related]
27. Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines.
Potenza N; Castiello F; Panella M; Colonna G; Ciliberto G; Russo A; Costantini S
PLoS One; 2016; 11(6):e0156908. PubMed ID: 27275761
[TBL] [Abstract][Full Text] [Related]
28. Expression of LC3A, LC3B and p62/SQSTM1 autophagy proteins in hepatocellular carcinoma (HCC) tissues and the predicted microRNAs involved in the autophagy-related pathway.
Wong MM; Aziz NA; Ch'ng ES; Armon S; Chook JB; Bong JJ; Peh SC; Wu YS; Teow SY
J Mol Histol; 2024 Jun; 55(3):317-328. PubMed ID: 38630414
[TBL] [Abstract][Full Text] [Related]
29. Effect of miR-4270 Suppression on Migration in Hepatocellular Carcinoma Cell Line (HepG2).
Akrami H; Gholami H; Fattahi MR; Zeraatiannejad M
Iran Biomed J; 2023 Jul; 27(4):167-72. PubMed ID: 37430248
[TBL] [Abstract][Full Text] [Related]
30. HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells.
Liu Y; Liu X; Luo M; Li Y; Li H
Discov Med; 2023 Dec; 35(179):1035-1042. PubMed ID: 38058068
[TBL] [Abstract][Full Text] [Related]
31. LncRNA
Huang Y; Li D; Lu L; Song D; Li P
Transl Cancer Res; 2024 Jan; 13(1):423-436. PubMed ID: 38410227
[TBL] [Abstract][Full Text] [Related]
32.
Bai HX; Qiu XM; Xu CH; Guo JQ
World J Gastrointest Oncol; 2024 May; 16(5):2123-2140. PubMed ID: 38764835
[TBL] [Abstract][Full Text] [Related]
33. Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma.
Tao L; Wang Y; Shen Z; Cai J; Zheng J; Xia S; Lin Z; Wan Z; Qi H; Jin R; Wang L; Xu J; Liang X
Hepatol Int; 2024 Feb; 18(1):91-107. PubMed ID: 37349627
[TBL] [Abstract][Full Text] [Related]
34. Long Non-coding RNA 02298 Promotes the Malignancy of HCC by Targeting the miR-28-5p/CCDC6 Pathway.
Wang J; Xu B; Liang L; Chen Q
Biochem Genet; 2024 Feb; ():. PubMed ID: 38381357
[TBL] [Abstract][Full Text] [Related]
35. C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5.
Wu Y; Xiang Q; Lv X; Xiang X; Feng Z; Tian S; Tang J; Xiang T; Gong J
J Gastroenterol Hepatol; 2021 Sep; 36(9):2581-2591. PubMed ID: 33576531
[TBL] [Abstract][Full Text] [Related]
36. [Plectin Promotes the Migration of Hepatocellular Carcinoma Cells Through Inducing F-actin Polymerization].
Xu R; Yang L; Song G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):60-66. PubMed ID: 38322534
[TBL] [Abstract][Full Text] [Related]
37. miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.
Ye X; Qiu R; He X; Hu Z; Zheng F; Huang X; Xie X; Chen F; Ou H; Lin G
Bioengineered; 2022 Jan; 13(1):1090-1102. PubMed ID: 34969357
[TBL] [Abstract][Full Text] [Related]
38. [Effect of CircCCND1 on the Malignant Biological Behaviors of H446 Lung Cancer Cells by Regulating the MiR-340-5p/TGIF1 Axis].
Dong Y; Zhu C; Liu X; Zhao J; Li Q
Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):161-169. PubMed ID: 38590190
[TBL] [Abstract][Full Text] [Related]
39. [miR-200a involvement in the biological behavior of hepatoma carcinoma cells by targeting the regulatory expression of mesenchymal-epithelial transition factor].
Zhang L; Chen W; Hou ZG; Yang X; Liu MH
Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1176-1181. PubMed ID: 38238951
[No Abstract] [Full Text] [Related]
40. miR-378a-5p represses Barrett's esophagus cells proliferation, migration and invasion through targeting TSPAN8.
Xie X; Wei D
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):97-103. PubMed ID: 38430035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
